CD4 and cutaneous mastocytosis: The WHO recommends CrAg screening in HIV-infected patients with a low CD4 T-cell count (<100 cells/μL) prior to ART initiation to prevent CM development and cryptococcal infections associated with immune reconstitution inflammatory syndrome [51].